Reducing the mitochondrial oxidative burden alleviates lipid-induced muscle insulin resistance in humans
https://t.co/0HHCpCxKlE
New paper out today in @ScienceAdvances
1/10 🧵👇
The @EASOobesityECN Best Thesis Award session is always an incredible showcase of the quality and diversity of research excellence from our future research leaders. Congratulations to all three incredible finalists @kathwills1@SBKJensen and our winner @R_K_Evans 🤩 #ECO2024
Congratulations Simon Jensen for being selected as one of the three @EASOobesityECN Best Thesis Candidates for #ECO2024
Come and hear Simon's presentation:
➡️ Monday 13th May at 17:20.
@EASOobesity@EASOpresident
Join the @EASOobesityECN board for the Best Thesis Award Session on 13th May at 17:00.
ECN Best Thesis Candidates, @R_K_Evans, Simon Jensen and @kathwills1 will present their work followed by an announcement of the winner of the EASO ECN 2024 Best Thesis award.
EASO congratulates the 2024 @EASOobesityECN Best Thesis finalists.
Please join us for their presentations at the EASO Early Career Network Best Thesis Award Session.
Monday 13 May, 2024 – 17.00-18.30 in Sala Grande
Researchers from @uni_copenhagen has found that exercise in combination with weight loss medication like #Wegovy and #Ozempic can help maintain a healthy weight - but a proper exit plan is needed.
Read the full article with @RasmusSandsdal & @SBKJensen
https://t.co/icxaqimr0g
Potent incretin‐based therapy for obesity: A systematic review and meta‐analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety - Müllertz - Obesity Reviews - Wiley Online Library https://t.co/tcpsyvfPEK
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by 1 year no treatment
Addition of supervised exercise to obesity pharmacotherapy seems to improve healthy weight maintenance after treatment termination
https://t.co/v7E9jkqcK9
Happy to share our recent study (and final paper of my PhD) on the importance of physical activity in the medical treatment of obesity.
Published in @eClinicalMed
@BiomedUCPH @UCPH_health@UCPH_Research@CTMetabUCPH
https://t.co/mY5mGduZNi
In observational, secondary analyses of a randomized controlled trial, researchers show that adults with #obesity and short sleep duration or poor #sleep quality regained weight during a 1-year #weightloss maintenance phase. https://t.co/9Xxqw8f5e2
Happy to share our new paper published in Obesity.
The combination of exercise and liraglutide improved glucose tolerance, beta cell function, and postprandial glucagon response. https://t.co/m2oQOd7AF9
@chrisrjuhl@STorekov@CTMetabUCPH @BiomedUCPH @UCPH_health@ObesitySociety
Our accepted paper: "Insufficient sleep predicts poor weight loss maintenance after one year" is now online in SLEEP @BiomedUCPH @CTMetabUCPH@ResearchSleep
https://t.co/cf4EyQk2DN
We had a great time at the #EISG2022 in Lausanne.
Enjoyed presenting some of our new data while gaining insight into the latest research on incretin hormones and their role in the pathogenesis and treatment of metabolic diseases.
@STorekov@Matteo_Fiorenza@SBKJensen@HoltJoachim
I wrote this thread a few years ago, but it remains highly relevant to our best understanding of obesity and the systems that regulate fat mass and energy.